Financials data is unavailable for this security.
View more
Year on year Imunon Inc had revenues fall -100.00% from 500.00k to 0.00, though the company grew net income from a loss of 35.90m to a smaller loss of 19.51m.
| Gross margin | -- |
|---|---|
| Net profit margin | -- |
| Operating margin | -- |
| Return on assets | -99.63% |
|---|---|
| Return on equity | -148.12% |
| Return on investment | -137.53% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Imunon Inc fell by 11.65m. However, Cash Flow from Investing totalled 11.01m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 19.02m for operations while cash used for financing totalled 3.64m.
| Cash flow per share | -1.80 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 0.5649 |
|---|---|
| Tangible book value per share | 0.5649 |
More ▼
Balance sheet in USDView more
| Current ratio | 2.30 |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | 0.00 |
|---|---|
| Total debt/total capital | 0.00 |
More ▼
